ReviewInternational journal of molecular sciences2025

Current and Emerging Therapies for Targeting the ERK1/2 & PI3K Pathways in Cancer.

Ethan Abizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.